Company: TXG
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001770787-25-000013
Chunk: 28

Company: 10x Genomics, Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 15
Chunk 28
---
0 Stoneridge Mall Road Investors LLC.10-Q001-3903510.411/12/202010.14#License Agreement, dated September 26, 2013, between the Registrant and the President and Fellows of Harvard College.S‑l333‑23336110.58/19/201910.14.1#Amendment No. 1 to License Agreement, dated October 25, 2018, between the Registrant and President and Fellows of Harvard College.S‑l333‑23336110.68/19/201910.15#Exclusive (Equity) Agreement dated October 15, 2015, between Epinomics, Inc, and The Board of Trustees of the Leland Stanford Junior University.S‑l333‑23336110.78/19/201910.15.1Amendment No. 1 to the License Agreement, dated February 1, 2017, between Epinomics and The Board of Trustees of the Leland Stanford Junior University.S‑l333‑23336110.88/19/201910.15.2#Amendment No. 2 to the License Agreement, dated July 27, 2018, between the Registrant and The Board of Trustees of the Leland Stanford Junior University.S‑l333‑23336110.98/19/201910.16Settlement and Patent Cross License Agreement, dated July 26, 2021, by and between the Registrant and Bio-Rad Laboratories, Inc.8-K001-3903510.17/27/202110.17+Form of Arbitration AgreementX

114

Table of Contents

Incorporated by ReferenceExhibitNumberExhibit TitleFormFile No.ExhibitFiling DateFiled Herewith19.1Amended and Restated Insider Trading Policy.10-K001-3903519.12/15/202423.1Consent of Independent Registered Public Accounting Firm.X24.1Power of Attorney (included in the signature page to this Annual Report).X31.1Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X31.2Certification of Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X32.1*Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X32